UBS Group
PROF

UBS Group’s Profound Medical PROF Stock Holding History

UBS Group’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$526K Buy
81,108
+75,603
+1,373% +$522K ﹤0.01% 6049
2025
Q4 		$43.3K Buy
5,505
+5,303
+2,625% +$34.1K ﹤0.01% 7299
2025
Q3 		$988 Sell
202
-3,553
-95% -$18.1K ﹤0.01% 9464
2025
Q2 		$22.2K Buy
3,755
+2,979
+384% +$15.8K ﹤0.01% 8365
2025
Q1 		$4.52K Buy
+776
New +$5.36K ﹤0.01% 9095
2024
Q3 		– Sell
-2,361
Closed -$19.8K – 9940
2024
Q2 		$19.8K Buy
2,361
+1,716
+266% +$13.8K ﹤0.01% 7312
2024
Q1 		$5.5K Buy
+645
New +$5.38K ﹤0.01% 7532
2023
Q1 		– Sell
-2,066
Closed -$22.5K – 10202
2022
Q4 		$22.5K Sell
2,066
-3,878
-65% -$21.1K ﹤0.01% 7535
2022
Q3 		$24K Buy
5,944
+5,739
+2,800% +$38.7K ﹤0.01% 7153
2022
Q2 		$1K Buy
+205
New +$1.62K ﹤0.01% 9933
2022
Q1 		– Sell
-1,428
Closed -$16K – 10755
2021
Q4 		$16K Buy
+1,428
New +$17.8K ﹤0.01% 8173
2021
Q2 		– Sell
-300
Closed -$6K – 9717
2021
Q1 		$6K Sell
300
-2,000
-87% -$48K ﹤0.01% 8248
2020
Q4 		$47K Sell
2,300
-492
-18% -$9.05K ﹤0.01% 6246
2020
Q3 		$49K Buy
2,792
+322
+13% +$5.12K ﹤0.01% 5667
2020
Q2 		$42K Sell
2,470
-1,075
-30% -$13.6K ﹤0.01% 6011
2020
Q1 		$34K Buy
3,545
+2,845
+406% +$36.9K ﹤0.01% 6122
2019
Q4 		$8K Buy
+700
New +$6.45K ﹤0.01% 7395

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

UBS Group's PROF Position: Q1 2026 in Review

UBS Group increased its Profound Medical (PROF) stake by 1,373% in Q1 2026, buying an estimated $522K and bringing the position to 81,108 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #6049.

UBS Group first reported a position in PROF in Q4 2019 and has held it in 17 quarters since. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • UBS Group held 81,108 shares of Profound Medical worth $526K as of Q1 2026.
  • UBS Group bought 75,603 Profound Medical shares in Q1 2026, an estimated $522K.
  • Profound Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6049 holding.
  • UBS Group first reported a position in Profound Medical in Q4 2019 and has held it in 17 quarters since.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.